Biodesix, Inc. BDSX
21.05 USD -0.73 (-3.35%)
At closeNov 3, 2026, 4:00 PM EST
21.05 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
20.74 Day range 22.89
5.26 52-week range 31.97
- YTD
- +209.56%
- 1 year
- +232.02%
Financial health
Altman Z-Score
-5.58 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.5×
FY 2018 5y median -2.9× FY 2025
P/S 0.6×
FY 2018 5y median 2.7× FY 2025
P/B -20.8×
FY 2018 5y median 7.3× FY 2025
P/FCF -2.2×
FY 2018 5y median -3.3× FY 2025
EV/EBITDA -4.8×
FY 2018 5y median -4.8× FY 2025
EV/Sales 1.2×
FY 2018 5y median 2.2× FY 2025
FCF Yield -46.1%
FY 2018 5y median -30.4% FY 2025
Profitability
Gross Margin 81.1%
FY 2018 5y median 73.5% FY 2025
Operating Margin -31.4%
FY 2018 5y median -75.1% FY 2025
Net Margin -39.8%
FY 2018 5y median -79.2% FY 2025
ROE 1430.6%
FY 2018 5y median -218.8% FY 2025
ROIC -38.9%
FY 2018 5y median -62.7% FY 2025
ROA -40.3%
FY 2018 5y median -52.6% FY 2025
Growth (YoY)
Revenue 24.1%
FY 2018 FY 2025
Operating Income 19.5%
FY 2018 FY 2025
EPS (diluted) 29.5%
FY 2018 FY 2025
Free Cash Flow 54.4%
FY 2018 FY 2025
Financial Health
Current Ratio 1.9×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 1.9×
FY 2018 5y median 1.9× FY 2025
Debt / Equity -29.6×
FY 2018 5y median 1.5× FY 2025
Net Debt / EBITDA -2.5×
FY 2018 5y median -0.9× FY 2025
Interest Coverage -3.6×
FY 2018 5y median -4.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
